Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05981196

Disparities Among Liver Transplant Patients

The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

End Stage Liver Disease Behavior Communication Digestive System Diseases Hepatic Insufficiency Liver Diseases Liver Failure

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic Arizona

Phoenix, Arizona, 85054, United States

Location status: Recruiting

Location contact

Gabrielle Montefiore

CONTACT

480-574-1288

Peter E. Frasco, MD

PRINCIPAL_INVESTIGATOR

About this study

Aim 1. Establish a longitudinal cohort of patients with end-stage liver dysfunction.

Aim 2. Examine interpersonal and structural factors associated with liver transplant evaluation and listing by patient characteristics (e.g., race, ethnicity, SES, gender).

Aim 3. Examine the use of stigmatizing language among patients undergoing liver transplant based on their demographic characteristics (e.g., race, ethnicity, SES, gender).

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with end-stage liver, kidney, or cardiac dysfunction.

Exclusion criteria

  • Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant.
  • Patients with potential medical exclusions for transplant.

Treatment and study plan

Primary outcomes

  1. Liver transplant waiting list

    Time frame: Approximately one year

    Number of subjects listed on the liver transplant waiting list

  2. Organ transplantation

    Time frame: Approximately one year

    Number of subject to receive an organ transplantation

Secondary outcomes

  1. Survival

    Time frame: Approximately one year post-transplant, or until you are removed from the transplant list

    Total number of subject alive

  2. Graft survival at six months

    Time frame: Six months post transplant

    Total number of subject to have a functioning graft at six months post transplant

  3. Graft survival at one year

    Time frame: One year post transplant

    Total number of subject to have a functioning graft at one year post transplant

Other outcomes

  1. Mortality

    Time frame: Approximately one year post-transplant, or until you are removed from the transplant list

    Total number of subject deaths

  2. Hospital length of stay

    Time frame: Approximately one year post-transplant, or until you are removed from the transplant list

    Total number of days subjects were admitted to the hospital

  3. ICU length of stay

    Time frame: Approximately one year post-transplant, or until you are removed from the transplant list

    Total number of days subjects were admitted to Intensive Care Unit (ICU)

  4. 30-day readmission

    Time frame: Approximately one year post-transplant, or until you are removed from the transplant list

    Number of subjects to experience a 30-day readmission

Study contacts

Contact information is provided by the study sponsor or research team.

Gabrielle Montefiore

CONTACT

480-574-1288

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Individual and Structural-level Determinants Associated With Disparities Among Liver Transplant Patients

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Aug 8, 2023
Registry last updated
Apr 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.